Modular transfection systems
CA 2434402 A1 · Owner: Schmidt, Hanns-Martin · Inventors: Siebenkotten, Gregor; Hein, Katharina; Lorbach, Elke
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The invention relates to a method for the transfection of cells using at least one protein capable of forming nucleoprotein filaments. Said protein is first modified by at least one functional constituent which influences at least one step of the transfection, and the nucleic acid to be transfected is then loaded with the modified protein. The nucleic acid and the protein form a filamentary complex, and said complex is then added to the cells to be transfected. The invention also relates to a transfection agent of nucleoprotein filaments (NPF), at least one protein forming a nucleoprotein filament being modified by at least one functional constituent for the transfection. The …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed January 10, 2002. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended January 10, 2022.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by January 10, 2024.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.